top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
CMS Administrator Dr. Mehmet Oz announced a new Trump administration initiative to provide up to $500 annually for hemp-derived CBD and THC products for eligible Medicare patients. The program, available to specific ACO participants, includes strict quality standards and physician oversight while facing an ongoing legal challenge from anti-marijuana groups.

Medicare Now Covering CBD and Hemp THC Products Thanks to New Dr. Oz Initiative

Apr 1, 2026

Source:

Tom Angell

Marijuana Moment

Medicare is taking a surprisingly green step forward, and it’s a big deal for patients who rely on the healing power of the plant. Dr. Mehmet Oz, now leading the Centers for Medicare & Medicaid Services, recently rolled out a new plan that helps cover the cost of hemp-derived products. For eligible folks, this means up to $500 a year to help pay for CBD and even some low-THC options. It’s all part of a broader push to make these natural alternatives more accessible to those who need them most, especially those managing serious health conditions.

What makes this especially interesting for our community is that the program doesn't just stop at CBD. While it stays within the federal legal limit of 0.3% THC, it allows for products with up to 3 milligrams of THC per serving. For many tokers, we know that a little bit of "the real deal" can significantly boost the effectiveness of CBD through the entourage effect. It’s a practical, common-sense move that recognizes how people actually use these products to feel better.

Of course, there are some ground rules. You won't find any flower or vapes here; the program is strictly for non-inhalable options like tinctures, gummies, or topicals. Everything also has to undergo rigorous third-party testing to ensure it's clean and accurately labeled. If you have a loved one on Medicare who has been curious about trying hemp for wellness, this is the perfect time to have them chat with their doctor. While some anti-cannabis groups are trying to block the move in court, a judge recently gave the green light for the launch to proceed. It’s a major win for accessibility and a sign that the conversation around cannabis is finally moving in a more positive, patient-focused direction. Stay tuned, because this could be the start of something even bigger for federal policy.

Recent Reviews

bottom of page